LobbyingVilin Bio Med lobbying by quarter
Vilin Bio Med's latest lobbying report covers Q2 2026, at $150K. The four quarters Q4 2025–Q3 2026 total $450K. Its first report covers Q2 2025; the issues it reports most are Economics/Economic Development.
Vilin Bio Med
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $450K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $50K | 1 |
| Q3 2025 | $150K | 1 |
| Q4 2025 | $150K | 1 |
| Q1 2026 | $150K | 1 |
| Q2 2026 | $150K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Economic development$650K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Commerce, Dept of (DOC)1 reports
- Food & Drug Administration (FDA)1 reports
- Health & Human Services, Dept of (HHS)1 reports
- Justice, Dept of (DOJ)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Ballard Partners | $650K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| MICHAEL LAROSA | (Lobbying limited to Congress) EA, Congresswoman Bean; Assistant to DepDir, OPM; Comm Dir, ENRC, Senate; DPCC, Comm Dir, Speaker Pelosi; Biden Harris Transition Team, Press Sec. First Lady; SA to President Biden; Press Sec. First Lady | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Ballard Partners | $150K |
| 04/20for Q1 | Ballard Partners | $150K |
| 01/20for Q4 2025 | Ballard Partners | $150K |
| 25/10/19for Q3 2025 | Ballard Partners | $150K |
| 25/07/18for Q2 2025 | Ballard Partners | $50K |
| 25/07/17for Q2 2025 | Ballard Partners | Under $5,000 |